Tay Therapeutics
Develops targeted small-molecule therapies for patients with serious diseases and high unmet medical need
Highlights
- New on EvolcAdded 2026-11-07
About Tay Therapeutics
Tay Therapeutics develops precision small-molecule medicines for defined patient populations, including therapies aimed at nonsense mutations in rare genetic diseases through its Tay-Enable platform.
The company selectively partners with other organisations to advance its pipeline. It has a collaboration with VYNE Therapeutics and receives license revenues from BET inhibitor programs, alongside non-dilutive grant funding.
Founded in 2020, Tay Therapeutics is headquartered in Dundee, UK. It was spun out from the University of Dundee and was formerly known as In4Derm.
Product: Targeted small-molecule drug discovery and development, including the Tay-Enable platform for assets targeting nonsense mutations in rare genetic diseases.
Jobs at Tay Therapeutics
Leadership
- Andrew Woodland · CEO & Co-FounderSource: company website
- Conor Woolfson · CFO/COOSource: company website
- Mark Bell · CTO & Co-FounderSource: company website
More biotech & pharma companies
Tek Optima Research
Custom AI, imaging software and the DeepInsight cell line imaging platform for life sciences and biotech teamsNew on EvolcTeva UK
Biopharmaceutical company supplying innovative, generic and biosimilar medicines to patients and healthcare providers in the UKNew on EvolcThe Electrospinning Company
Electrospun biomaterials and coatings for medical device developers, from feasibility studies through regulated manufacturingNew on EvolcTheolytics
Develops oncolytic adenovirus immunotherapies for patients with solid tumours and cancers of high unmet needNew on EvolcTheramex
Specialty pharmaceuticals for women’s health, including contraception, fertility, menopause and osteoporosis treatmentsRemote-friendlyThornton & Ross
Consumer healthcare and generic medicines for UK patients and households, part of the STADA GroupNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.